Sungyoung Lee

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 203 citations · Full text

Biosimilar Ct-p13, Originator Infliximab, Gastroenterology +5

Associations of <i>ABCB1, ABCC2</i>, and <i>ABCG2</i> polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer

Ji‐Youn Han, Hyeong‐Seok Lim, Yeon‐Kyeong Yoo et al. · Cancer · 2007 · 196 citations · Full text

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

Dae‐Hyun Yoo, Artur Racewicz, Jan Brzezicki et al. · Arthritis Research & Therapy · 2016 · 170 citations · Full text

USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer

Sanguine Byun, Sungyoung Lee, Ji‐Hoon Lee et al. · Clinical Cancer Research · 2013 · 146 citations · Full text

Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR

Sung Keun Jung, Mee‐Hyun Lee, Do Young Lim et al. · Journal of Biological Chemistry · 2014 · 129 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +11